Page last updated: 2024-10-16

benzaldehyde and Carcinoma, Mucoepidermoid

benzaldehyde has been researched along with Carcinoma, Mucoepidermoid in 1 studies

Carcinoma, Mucoepidermoid: A tumor of both low- and high-grade malignancy. The low-grade grow slowly, appear in any age group, and are readily cured by excision. The high-grade behave aggressively, widely infiltrate the salivary gland and produce lymph node and distant metastases. Mucoepidermoid carcinomas account for about 21% of the malignant tumors of the parotid gland and 10% of the sublingual gland. They are the most common malignant tumor of the parotid. (From DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p575; Holland et al., Cancer Medicine, 3d ed, p1240)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sreerama, L1
Sladek, NE1

Other Studies

1 other study available for benzaldehyde and Carcinoma, Mucoepidermoid

ArticleYear
Over-expression of glutathione S-transferases, DT-diaphorase and an apparently tumour-specific cytosolic class-3 aldehyde dehydrogenase by Warthin tumours and mucoepidermoid carcinomas of the human parotid gland.
    Archives of oral biology, 1996, Volume: 41, Issue:6

    Topics: Adenolymphoma; Adenoma, Pleomorphic; Aldehyde Dehydrogenase; Antineoplastic Agents; Antineoplastic A

1996